Table 2.
Drug | Brand names | Dosage range/use | Half-life range | Number of participants baseline | Number of participants Year 1 |
---|---|---|---|---|---|
Carbidopa-Levodopa | Atamet® | 25–100 mg | 60 to 90 min | 19 | 22 |
Sinamet® | |||||
Pramipexole | Mirapex® | 0.5–1.5 mg | 8–12 h | 6 | 8 |
Amantadine | Symmetrel® | 100 mg | 2–4 h | 2 | 5 |
Ropinirole | Requip® | 0.5–12 mg | 6 h | 2 | 3 |
Requip XL® | |||||
Entacapone | Comtan® | 200 mg | 0.5–2.5 h | 1 | 0 |
Apomorphine | Apokyn® | 10 mg/3 ml | 0.5 to 1 h | 1 | 0 |
Rotigotine Transdermal Patch | Neupro® | 2–6 mg patches | 5–7 h | 2 | 4 |
Selegiline | Zelepar® | 5 mg | 2–10 h | 1 | 1 |